Navigation Links
ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
Date:4/13/2009

OAKWOOD VILLAGE, Ohio, April 14 /PRNewswire/ -- ViewRay Incorporated, a medical device company, announces the close of the second tranche of their $25M Series B financing. Funding was triggered by the company's achievement of a major milestone towards the development of their image guided cancer therapy device, the Renaissance(TM) System. The financing was led by OrbiMed Advisors and Fidelity Biosciences, and was joined by Aisling Capital and Kearny Venture Partners.

"These funds will allow us to continue developing our novel radiation therapy device for the treatment of cancer patients. We believe our system's simultaneous real-time volumetric imaging may provide a tremendous clinical advantage over systems in use today," said Dr. James F. Dempsey, founder and inventor of the technology, and Chief Scientific Officer of the company.

Additionally, the company is announcing that it has entered into an exclusive development and supply agreement with Siemens AG, Healthcare Sector for magnetic resonance imaging (MRI) technology. This collaboration will accelerate the development of ViewRay's Renaissance(TM) System.

"Siemens is a recognized leader in the field of MRI and their expertise in this area will enable us to incorporate state-of-the-art imaging technology into our product," said Dr. John L. Patrick, Senior V.P. of Engineering.

"We are excited to work with ViewRay to explore the capabilities of MR beyond diagnostics and into the field of radiation therapy with a clear goal to improve therapy treatment to the benefit of the patient," said Walter Marzendorfer, head of Magnetic Resonance, Siemens AG, Healthcare Sector.

About ViewRay Incorporated:

ViewRay Incorporated is developing an advanced system to treat cancer patients: the world's first real-time MRI guided radiation therapy device. The Renaissance(TM) System technology will continuously image the patien
'/>"/>

SOURCE ViewRay Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
3. Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference
4. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
5. Genta Incorporated to Present at the BIO CEO & Investor Conference
6. Auditors for Genta Incorporated Express Going Concern Qualification
7. Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
8. Accuray Incorporateds CEO to Speak at CitiGroup Healthcare Conference
9. Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights
10. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
11. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 Research and Markets ... of Jain PharmaBiotech,s new report "Nanobiotechnology ... offering. An increasing use ... industries is anticipated. Nanotechnology will be applied ... from formulations for optimal delivery to diagnostic ...
(Date:9/2/2015)... Research and Markets ... Jain PharmaBiotech,s new report "Biochips and Microarrays ... offering. This report is an analysis ... The report starts with a description of technologies ... include array comparative genomic hybridization (CGH), copy number ...
(Date:9/2/2015)... 02, 2015 Research and ... Jain PharmaBiotech,s new report "Gene Therapy - Technologies, ... The markets for gene therapy are difficult to estimate ... and it is marketed in China ... the years 2014-2024. The estimates are based on epidemiology ...
(Date:9/2/2015)... ... 02, 2015 , ... Drug companies increasingly are adopting a ... reveals in its new report that the U.S. will generate the greatest demand ... the most market demand. , BCC Research examines plant-derived drugs in its ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 2Plant-derived Compounds Poised to Assume Greater Role in Global Drug Markets, According to BCC Research 3
... Development of Farletuzumab for Ovarian CancerAgreement Highlights Lonza,s ... Pa. and BASEL, Switzerland, May 19 Morphotek(R), ... America, and Lonza Group Ltd jointly announced today ... to support the development and manufacturing of a ...
... Therapeutic for IBD with Novel Mode of ActionMOUNTAIN ... Inc., today announced that data from the company,s ... Crohn,s disease Trial) Phase II/III clinical trial of ... will be presented in an oral session at ...
... to present Phase 2 data on perifosine for ... Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS ... therapy and oncology, today announced that results supporting ... compound, AEZS-108, in prostate cancer, will be presented ...
Cached Biology Technology:Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 2Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 3Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5AEterna Zentaris to Present Data Supporting Evaluation of AEZS-108 in Prostate Cancer at Upcoming ASCO Meeting 2AEterna Zentaris to Present Data Supporting Evaluation of AEZS-108 in Prostate Cancer at Upcoming ASCO Meeting 3
(Date:8/6/2015)... SAN JOSE, Calif. , Aug. 6, 2015 ... the leading developer of human interface solutions, today ... and TouchPad technologies on Windows 10. Microsoft leveraged ... fundamental to the operating system. ... and drivers are fully certified with Microsoft,s Precision ...
(Date:8/4/2015)... Research and ... addition of the "Digital Forensics Market ... (Computer Forensics, Network Forensics, Mobile Device Forensics, ... and Region - Global Forecast to 2020" ... By Component (Hardware, Software, and Service), Sub-Segment ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julio de 2015 ... sobre Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 ... . La conferencia celebra su décimo ... se ha convertido en una de las reuniones anuales ... ,ómicas, y es una de las conferencias científicas más ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... mammals arose in the Triassic period, over 225 million years ... as Morganucodon from England, Megazostrodon from ... differentiated teeth (incisors, canines, molars) and large brains and were ... make them stand apart from their reptile ancestors, and which ...
... 2013) When a woman becomes pregnant, she knows it ... the health of herself and the health of her baby. ... and the Eurpean Federation of Periodontology (EFP) urge pregnant women ... women with periodontal disease may be at risk of adverse ...
... United States there are millions of sports related concussions each ... fear of being benched trumps the fear of permanent brain ... diagnose concussions on the sidelines. , Researchers at San ... , A team led by Daniel Goble, an exercise and ...
Cached Biology News:Not the end of the world: Why Earth's greatest mass extinction was the making of modern mammals 2Expectant mothers' periodontal health vital to health of her baby 2Combating concussions 2Combating concussions 3
Fujifilm BAS-1800II provides the ideal configuration for a low-cost imager that requires only a small amount of space in the laboratory. The small imager for accurate high-throughput screening...
When added to StemSep T Cell Enrichment cocktail, human TCRab TAC is designed to deplete human TCRab from samples to isolate gd T cells....
... The Aquarius 384 is a ... Aquarius 384-well head is a unique ... washing using the included wash system. ... 250 microplate stacker system. Will ...
... The Eclipse C1 Plus is a ... highest-quality digital imaging with an ultra-compact and ... of the C1 Plusboost optical performance to ... acquisition.The system alsoincludes support for X and ...
Biology Products: